Monday 31 May
Atherosclerosis: metabolism dysfunction drives inflammation in the vessels
New Phenotypes for Stratification and Modeling of Atherosclerosis
Gerard Pasterkamp, Utrecht, The Netherlands
Gerard Pasterkamp, Utrecht, The Netherlands
Endothelial Mechanotransduction, Metabolism and Lipoprotein Transport in Atherosclerosis
Jan Borén, Gothenburg, Sweden
Jan Borén, Gothenburg, Sweden
The Interface of Immune and Metabolic Responses in Atherosclerosis
Esther Lutgens, Amsterdam, The Netherlands
Esther Lutgens, Amsterdam, The Netherlands
Coronary Artery Calcification and its Progression: What Does it Really Mean?
Renu Virmani, Baltimore, USA
Renu Virmani, Baltimore, USA
Tuesday 01 June
Future CVD management: from gene to phenotype to treatment
From genetic discovery to clinical interventions to combat atherosclerosis
Mark Daly, Helsinki, Finland
Mark Daly, Helsinki, Finland
Does circardian rythm influence lipid metabolism and immune system?
Paolo Sassone-Corsi, Irvine, USA
Paolo Sassone-Corsi, Irvine, USA
Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue?
Charalambos Antoniades, Oxford, UK
Charalambos Antoniades, Oxford, UK
SPPARM alpha agonist as for Nutrient and Energy Metabolism - Mechanisms and Therapeutic Opportunities
Jean-Charles Fruchart, Lille/Basel, France
Jean-Charles Fruchart, Lille/Basel, France
Wednesday 02 June
The rise of cardiometabolic disease as global health threat: towards the UN 2030 goals
Exercise, inactivity, and circadian rhythms - re-setting the clock in metabolic disease
Juleen Zierath, Stockholm, Sweden
Juleen Zierath, Stockholm, Sweden
The Mediterranean diet, its components, and cardiovascular disease
Miguel Martinez-Gonzalez, Pamplona, Spain
Miguel Martinez-Gonzalez, Pamplona, Spain
Gender and Cardiovascular Disease
DeLisa Fairweather, Baltimore, USA
DeLisa Fairweather, Baltimore, USA
AVSD management: will the future look smarter?
Thomas F. Lüscher, Zürich, Switzerland
Thomas F. Lüscher, Zürich, Switzerland
